Press releases

Nightingale Health acquires all intellectual property assets of the Velvet™ blood collection device and secures its position as the sole provider of a fully integrated remote health check solution

Jun 27, 2024
Flagging notifications

Disclosure under Chapter 9, Section 10 of the Securities Markets Act (Cor Group Oy)

Jun 18, 2024
Flagging notifications

Disclosure under Chapter 9, Section 10 of the Securities Markets Act (Pasi Soininen)

Jun 18, 2024
Flagging notifications

Disclosure under Chapter 9, Section 10 of the Securities Markets Act (Teemu Suna)

Jun 18, 2024
Flagging notifications

Disclosure under Chapter 9, Section 10 of the Securities Markets Act (Antti Kangas)

Jun 18, 2024
Company releases

Conversion of Nightingale Health Plc’s Series A shares to Series B shares

Jun 11, 2024
Press releases

Health check based on advanced blood analysis technology builds a better foundation for public health

Jun 06, 2024
Company releases

Nightingale Health’s Board of Directors extended the subscription period of employee option rights

May 23, 2024
Press releases

Nightingale Health launches new website aligned with the B2B and B2G strategy

May 21, 2024
Company releases

Inside information: Nightingale Health achieves one of its business targets for this financial year by winning contracts in medical research with a total contract value of at least EUR 3.2 million

Apr 25, 2024
Press releases

Nightingale Health to establish a laboratory in the United States with Weill Cornell Medicine as the first customer

Apr 16, 2024
Company releases

Supplement to the release: Inside Information: Nightingale Health enters into agreement to analyze 50,000 blood samples with Kaiser Foundation Health Plan, Inc.

Apr 12, 2024
Company releases

Inside Information: Nightingale Health enters into agreement to analyze 50,000 blood samples with Kaiser Foundation Health Plan, Inc.

Apr 12, 2024
Company releases

Nightingale Health has completed the acquisition of Welltus Inc

Mar 29, 2024
Company releases

Correction: Conversion of Nightingale Health Plc’s EMP shares to Series B shares

Mar 21, 2024